Arterra Bioscience S.p.A. (BIT:ARBS)
Italy · Delayed Price · Currency is EUR 3.110
-0.080 (-2.51%)
Aug 17, 2026, 1:44 PM CET
Arterra Bioscience Revenue
In the year 2025, Arterra Bioscience had annual revenue of 6.12M EUR with 16.12% growth. Arterra Bioscience had revenue of 2.97M in the half year ending December 31, 2025, with 5.00% growth.
Revenue
6.12M
Revenue Growth
+16.12%
P/S Ratio
4.51
Revenue / Employee
n/a
Employees
36
Market Cap
21.24M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.12M | 848.83K | 16.12% |
| Dec 31, 2024 | 5.27M | 315.40K | 6.37% |
| Dec 31, 2023 | 4.95M | -352.62K | -6.65% |
| Dec 31, 2022 | 5.30M | 695.23K | 15.09% |
| Dec 31, 2021 | 4.61M | 299.54K | 6.95% |
| Dec 31, 2020 | 4.31M | 681.98K | 18.80% |
| Dec 31, 2019 | 3.63M | 648.43K | 21.77% |
| Dec 31, 2018 | 2.98M | 232.93K | 8.48% |
| Dec 31, 2017 | 2.75M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.71B |
| Amplifon | 2.40B |
| DiaSorin | 1.18B |
| EL.En. | 595.51M |
| GPI S.p.A. | 546.18M |
| Svas Biosana | 141.56M |
| Talea Group | 132.17M |
| Farmacosmo | 56.13M |
Arterra Bioscience News
- 4 weeks ago - Arterra Bioscience Earnings release: Q2 2026 - Filings
- 3 months ago - Arterra Bioscience Earnings release: Q1 2026 - Filings
- 5 months ago - Arterra Bioscience Earnings release: H2 2025 - Filings
- 6 months ago - Arterra Bioscience Earnings release: Q4 2025 - Filings
- 10 months ago - Arterra Bioscience Earnings release: Q3 2025 - Filings
- 11 months ago - Arterra Bioscience Earnings release: H1 2025 - Filings
- 11 months ago - Arterra Bioscience Quarterly report: H1 2025 - Filings